Skin Boosters
BELOTERO references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 10090
Belotero Revive
Belotero Revive is an injectable booster that targets early signs of photodamaged skin. It addresses dehydration, superficial fine lines, and uneven skin texture to improve hydration and overall skin quality.
Volume
1x1mL
Laboratory
Merz Aesthetics
Origin
Germany
Indication
Skin hydration and skin quality
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Belotero Revive is the skin quality and skin booster injectable of the BELOTERO range. It is an injectable resorbable implant that treats early signs of photodamaged skin through rehydration of dry and very dry skin and smoothening of superficial fine lines, and is indicated for early signs of photodamaged facial skin characterised by dehydration and the presence of superficial fine lines.
Each 1 mL syringe contains cross-linked sodium hyaluronate 20 mg/ml and glycerol 17.5 mg/ml in phosphate buffer at pH 7. The sodium hyaluronate is produced by fermentation of Streptococcus equi. This presentation contains no lidocaine. It is placed in the mid- to deep dermis by authorised healthcare professionals, and the treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 24 mL.
Belotero Revive UK supply is handled by ALLPARA on a business-to-business basis, with batch-level traceability on every unit and documentation available on request. Wholesale pricing is available to registered professional buyers.
Key Benefits of Belotero Revive
- Injectable resorbable implant for early signs of photodamaged facial skin, characterised by dehydration and superficial fine lines
- Cross-linked sodium hyaluronate 20 mg/ml with glycerol 17.5 mg/ml, in phosphate buffer at pH 7
- Glycerol as a second component is the formulation difference that separates Revive from the fillers in the range
- Contains no lidocaine, so the amide-anaesthetic contraindication that applies to the other grades does not apply here
- Rehydrates dry and very dry skin and smooths superficial fine lines rather than building facial volume
- Placed in the mid- to deep dermis by authorised healthcare professionals
- The treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 24 mL
- Hyaluronate produced by fermentation of Streptococcus equi rather than from an animal source
- Manufactured by Anteis SA in Plan-les-Ouates, Geneva, Switzerland, part of the Merz Aesthetics group
- Batch-level traceability on every unit supplied by ALLPARA, with documentation available to professional buyers on request
Indications and Professional Use
Main indications
- Early signs of photodamaged facial skin, characterised by dehydration and the presence of superficial fine lines
- Rehydration of dry and very dry skin
- Smoothening of superficial fine lines
Professional use
This product is designed to be injected only by authorised healthcare practitioners who have appropriate training and experience and who are qualified or accredited in accordance with national law. It is not for retail sale to consumers and not for self-application. Injection technique, plane, quantity and patient selection are determined by the treating practitioner, and the injection depth is specific to this grade and must not be inherited from another grade in the range.
Treatment areas
- Facial skin
- Skin hydration
- Skin radiance and glow
- Skin tone evenness and complexion
- Skin firmness and softness
- Superficial fine lines and texture irregularities
- Redness and pigmentation linked to sun damage
Patient profile
Suitable for adult patients assessed as appropriate by the treating practitioner. BELOTERO Revive is contra-indicated in cases of known hypersensitivity to any of its components, especially sodium hyaluronate, glycerol or BDDE; in pregnant and breast-feeding women; in patients under 18 years old; in patients presenting a general infection; and in patients presenting an active auto-immune disease. It must not be injected into blood vessels, or into skin areas presenting active cutaneous inflammation or infection. This presentation contains no lidocaine, so the amide-anaesthetic contraindication that applies to the lidocaine-containing grades in the range does not apply here. Patient selection and suitability are determined by the practitioner at consultation.
How Belotero Revive Works
Belotero Revive works through two components rather than one. Cross-linked sodium hyaluronate at 20 mg/ml provides the hydrating, revitalising base, and glycerol at 17.5 mg/ml is the second component, which is the formulation difference that separates Revive from the BELOTERO fillers. It acts as an injectable resorbable implant that rehydrates dry and very dry skin and smooths superficial fine lines, rather than building facial volume.
It is placed in the mid- to deep dermis, and the treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 24 mL. Because the target is skin quality rather than facial structure, it is directed at early photodamage characterised by dehydration and superficial fine lines. This presentation contains no lidocaine.
Why Order From Allpara
Allpara offers genuine, verified BELOTERO products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
What does Belotero Revive do?
Belotero Revive is an injectable resorbable implant that treats early signs of photodamaged skin through rehydration of dry and very dry skin and smoothening of superficial fine lines. It works on skin quality rather than correcting folds or restoring volume, and is applied by an authorised healthcare professional.
How does Belotero Revive differ from a BELOTERO dermal filler?
Belotero Revive contains cross-linked sodium hyaluronate 20 mg/ml together with glycerol 17.5 mg/ml, and contains no lidocaine. The glycerol is the formulation difference that separates it from the fillers in the range, which correct lines, folds and volume loss. They sit in different product categories and are not interchangeable.
Which treatment areas is Belotero Revive used for?
It treats early signs of photodamaged facial skin, characterised by dehydration and the presence of superficial fine lines, and is placed in the mid- to deep dermis. Area selection and treatment intervals are the treating practitioner's decisions.
How often can Belotero Revive treatment be repeated?
The treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 24 mL. The regimen for an individual patient is set by the treating practitioner.
Customer Reviews
5.0
Based on 1 review
Verified Purchases
Verified buyer reviews
Sign in to your B2B account to read what other practitioners say about this product.
Sign in to read reviews →
More from Merz
Dermal Fillers
RADIESSE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
RADIESSE Products
View all 2
Clinic alternatives
Mesotherapy
Biorevitalisation
/ Recently viewed
Pick up where you left off
Belotero Revive is the skin quality and skin booster injectable of the BELOTERO range. It is an injectable resorbable implant that treats early signs of photodamaged skin through rehydration of dry and very dry skin and smoothening of superficial fine lines, and is indicated for early signs of photodamaged facial skin characterised by dehydration and the presence of superficial fine lines.
Each 1 mL syringe contains cross-linked sodium hyaluronate 20 mg/ml and glycerol 17.5 mg/ml in phosphate buffer at pH 7. The sodium hyaluronate is produced by fermentation of Streptococcus equi. This presentation contains no lidocaine. It is placed in the mid- to deep dermis by authorised healthcare professionals, and the treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 24 mL.
Belotero Revive UK supply is handled by ALLPARA on a business-to-business basis, with batch-level traceability on every unit and documentation available on request. Wholesale pricing is available to registered professional buyers.
Key Benefits of Belotero Revive
- Injectable resorbable implant for early signs of photodamaged facial skin, characterised by dehydration and superficial fine lines
- Cross-linked sodium hyaluronate 20 mg/ml with glycerol 17.5 mg/ml, in phosphate buffer at pH 7
- Glycerol as a second component is the formulation difference that separates Revive from the fillers in the range
- Contains no lidocaine, so the amide-anaesthetic contraindication that applies to the other grades does not apply here
- Rehydrates dry and very dry skin and smooths superficial fine lines rather than building facial volume
- Placed in the mid- to deep dermis by authorised healthcare professionals
- The treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 24 mL
- Hyaluronate produced by fermentation of Streptococcus equi rather than from an animal source
- Manufactured by Anteis SA in Plan-les-Ouates, Geneva, Switzerland, part of the Merz Aesthetics group
- Batch-level traceability on every unit supplied by ALLPARA, with documentation available to professional buyers on request
Indications and Professional Use
Main indications
- Early signs of photodamaged facial skin, characterised by dehydration and the presence of superficial fine lines
- Rehydration of dry and very dry skin
- Smoothening of superficial fine lines
Professional use
This product is designed to be injected only by authorised healthcare practitioners who have appropriate training and experience and who are qualified or accredited in accordance with national law. It is not for retail sale to consumers and not for self-application. Injection technique, plane, quantity and patient selection are determined by the treating practitioner, and the injection depth is specific to this grade and must not be inherited from another grade in the range.
Treatment areas
- Facial skin
- Skin hydration
- Skin radiance and glow
- Skin tone evenness and complexion
- Skin firmness and softness
- Superficial fine lines and texture irregularities
- Redness and pigmentation linked to sun damage
Patient profile
Suitable for adult patients assessed as appropriate by the treating practitioner. BELOTERO Revive is contra-indicated in cases of known hypersensitivity to any of its components, especially sodium hyaluronate, glycerol or BDDE; in pregnant and breast-feeding women; in patients under 18 years old; in patients presenting a general infection; and in patients presenting an active auto-immune disease. It must not be injected into blood vessels, or into skin areas presenting active cutaneous inflammation or infection. This presentation contains no lidocaine, so the amide-anaesthetic contraindication that applies to the lidocaine-containing grades in the range does not apply here. Patient selection and suitability are determined by the practitioner at consultation.
How Belotero Revive Works
Belotero Revive works through two components rather than one. Cross-linked sodium hyaluronate at 20 mg/ml provides the hydrating, revitalising base, and glycerol at 17.5 mg/ml is the second component, which is the formulation difference that separates Revive from the BELOTERO fillers. It acts as an injectable resorbable implant that rehydrates dry and very dry skin and smooths superficial fine lines, rather than building facial volume.
It is placed in the mid- to deep dermis, and the treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 24 mL. Because the target is skin quality rather than facial structure, it is directed at early photodamage characterised by dehydration and superficial fine lines. This presentation contains no lidocaine.
Why Order From Allpara
Allpara offers genuine, verified BELOTERO products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
What does Belotero Revive do?
Belotero Revive is an injectable resorbable implant that treats early signs of photodamaged skin through rehydration of dry and very dry skin and smoothening of superficial fine lines. It works on skin quality rather than correcting folds or restoring volume, and is applied by an authorised healthcare professional.
How does Belotero Revive differ from a BELOTERO dermal filler?
Belotero Revive contains cross-linked sodium hyaluronate 20 mg/ml together with glycerol 17.5 mg/ml, and contains no lidocaine. The glycerol is the formulation difference that separates it from the fillers in the range, which correct lines, folds and volume loss. They sit in different product categories and are not interchangeable.
Which treatment areas is Belotero Revive used for?
It treats early signs of photodamaged facial skin, characterised by dehydration and the presence of superficial fine lines, and is placed in the mid- to deep dermis. Area selection and treatment intervals are the treating practitioner's decisions.
How often can Belotero Revive treatment be repeated?
The treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 24 mL. The regimen for an individual patient is set by the treating practitioner.
More from Merz
View laboratory →Customer Reviews
5.0
Based on 1 review
Verified Purchases
Verified buyer reviews
Sign in to your B2B account to read what other practitioners say about this product.
Sign in to read reviews →
* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.